Skip to content
CONTACT US
CAREERS
Share
ABOUT US
AT A GLANCE
MANAGEMENT TEAM
BOARD OF DIRECTORS
SCIENTIFIC ADVISORS
PARTNERS
AlloCAR T™
HISTORY OF CAR T
NEXT REVOLUTION IN CELL THERAPY
PLATFORM FOR TOMORROW
ON-DEMAND AVAILABILITY
PIPELINE
AlloCAR T™ PIPELINE
DATABRIEF
CLINICAL TRIALS
EXPANDED ACCESS
SCIENTIFIC PUBLICATIONS
OUR CULTURE
ESG REPORT
WE ARE ONE ALLOGENE
REVOLUTIONIZING CELL THERAPY
DIVERSITY, EQUITY, INCLUSION AND BELONGING
JOIN THE ALLOGENE COMMUNITY
NEWS CENTER
PRESS RELEASES
EVENTS
PERSPECTIVES
OUR TWEETS
COMMUNITY GUIDELINES
INVESTORS
IR OVERVIEW
NEWS & EVENTS
PRESS RELEASES
EVENTS
PRESENTATIONS
STOCK INFORMATION
STOCK QUOTE & CHART
HISTORIC PRICE LOOKUP
INVESTMENT CALCULATOR
CORPORATE GOVERNANCE
DOCUMENTS & CHARTERS
ESG REPORT
BOARD OF DIRECTORS
MANAGEMENT
COMMITTEE COMPOSITION
FINANCIALS & FILINGS
SEC FILINGS
RESOURCES
INVESTOR FAQs
EMAIL ALERTS
IR INQUIRY
ABOUT US
AT A GLANCE
MANAGEMENT TEAM
BOARD OF DIRECTORS
SCIENTIFIC ADVISORS
PARTNERS
AlloCAR T™
HISTORY OF CAR T
NEXT REVOLUTION IN CELL THERAPY
PLATFORM FOR TOMORROW
ON-DEMAND AVAILABILITY
PIPELINE
AlloCAR T™ PIPELINE
DATABRIEF
CLINICAL TRIALS
EXPANDED ACCESS
SCIENTIFIC PUBLICATIONS
OUR CULTURE
ESG REPORT
WE ARE ONE ALLOGENE
REVOLUTIONIZING CELL THERAPY
DIVERSITY, EQUITY, INCLUSION AND BELONGING
JOIN THE ALLOGENE COMMUNITY
NEWS CENTER
PRESS RELEASES
EVENTS
PERSPECTIVES
OUR TWEETS
COMMUNITY GUIDELINES
INVESTORS
IR OVERVIEW
NEWS & EVENTS
PRESS RELEASES
EVENTS
PRESENTATIONS
STOCK INFORMATION
STOCK QUOTE & CHART
HISTORIC PRICE LOOKUP
INVESTMENT CALCULATOR
CORPORATE GOVERNANCE
DOCUMENTS & CHARTERS
ESG REPORT
BOARD OF DIRECTORS
MANAGEMENT
COMMITTEE COMPOSITION
FINANCIALS & FILINGS
SEC FILINGS
RESOURCES
INVESTOR FAQs
EMAIL ALERTS
IR INQUIRY
Preclinical Evaluation of Allogeneic CD19 CAR T Cells Expressing an Anti-Rejection CD70 CAR
